4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Flunarizine.
Abiraterone
The serum concentration of Flunarizine can be increased when it is combined with Abiraterone.
Acepromazine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Acepromazine.
Advertisement
Aceprometazine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Aceprometazine.
Acetyl Sulfisoxazole
The metabolism of Flunarizine can be decreased when combined with Acetyl sulfisoxazole.
Alfaxalone
The risk or severity of adverse effects can be increased when Flunarizine is combined with Alfaxalone.
Advertisement
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Flunarizine.
Alfuzosin
The risk or severity of hypotension can be increased when Alfuzosin is combined with Flunarizine.
Alphaprodine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Alphaprodine.
Advertisement
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Flunarizine.
Amiodarone
The metabolism of Flunarizine can be decreased when combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Flunarizine is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Flunarizine.
Amobarbital
The metabolism of Flunarizine can be increased when combined with Amobarbital.
Amorolfine
The therapeutic efficacy of Amorolfine can be increased when used in combination with Flunarizine.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Flunarizine.
Amphetamine
Amphetamine may decrease the sedative activities of Flunarizine.
Amphotericin B
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Flunarizine.
amphotericin B liposomal
The therapeutic efficacy of Amphotericin B can be increased when used in combination with Flunarizine.
Anidulafungin
The therapeutic efficacy of Anidulafungin can be increased when used in combination with Flunarizine.
Apalutamide
The serum concentration of Flunarizine can be decreased when it is combined with Apalutamide.
Aprepitant
The metabolism of Flunarizine can be increased when combined with Aprepitant.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Flunarizine.
Artemether
The metabolism of Flunarizine can be decreased when combined with Artemether.
Articaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Flunarizine.
Atomoxetine
The metabolism of Flunarizine can be decreased when combined with Atomoxetine.
Azelastine
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azithromycin
The metabolism of Flunarizine can be decreased when combined with Azithromycin.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Flunarizine.
Barbexaclone
The metabolism of Flunarizine can be increased when combined with Barbexaclone.
Barbital
The metabolism of Flunarizine can be increased when combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Flunarizine is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Flunarizine is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Benzocaine.
Benzoic Acid
The therapeutic efficacy of Benzoic Acid can be increased when used in combination with Flunarizine.
Benzphetamine
Benzphetamine may decrease the sedative activities of Flunarizine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Flunarizine is combined with Benzyl alcohol.
Benzylpenicilloyl polylysine
Flunarizine may decrease effectiveness of Benzylpenicilloyl Polylysine as a diagnostic agent.
BETAHISTINE
The therapeutic efficacy of Betahistine can be decreased when used in combination with Flunarizine.
Betaxolol
The metabolism of Flunarizine can be decreased when combined with Betaxolol.
Bifonazole
The therapeutic efficacy of Bifonazole can be increased when used in combination with Flunarizine.
Bortezomib
The metabolism of Flunarizine can be decreased when combined with Bortezomib.
Brexpiprazole
The risk or severity of adverse effects can be increased when Flunarizine is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Flunarizine.
Bromperidol
The risk or severity of adverse effects can be increased when Flunarizine is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Flunarizine.
Brotizolam
The risk or severity of adverse effects can be increased when Flunarizine is combined with Brotizolam.
Bunazosin
The risk or severity of hypotension can be increased when Bunazosin is combined with Flunarizine.
Bupivacaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Bupivacaine.
Buprenorphine
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Bupropion
The metabolism of Flunarizine can be decreased when combined with Bupropion.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Flunarizine.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Flunarizine.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Flunarizine.
Butamben
The risk or severity of adverse effects can be increased when Flunarizine is combined with Butamben.
Butenafine
The therapeutic efficacy of Butenafine can be increased when used in combination with Flunarizine.
Butobarbital
The risk or severity of adverse effects can be increased when Flunarizine is combined with Butethal.
Butoconazole
The therapeutic efficacy of Butoconazole can be increased when used in combination with Flunarizine.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Flunarizine.
Caffeine
The metabolism of Flunarizine can be decreased when combined with Caffeine.
Calcium Acetate
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium Acetate.
Calcium Carbonate
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium Carbonate.
Calcium Chloride
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium Chloride.
Calcium Chloride Anhydrous
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium Chloride.
Calcium Citrate
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium Citrate.
Calcium Glubionate
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium glubionate.
Calcium gluceptate
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium Gluceptate.
Calcium Gluconate
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium gluconate.
Calcium Lactate
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium lactate.
CALCIUM LEVULINATE
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium levulinate.
Capecitabine
The metabolism of Flunarizine can be decreased when combined with Capecitabine.
Carbamazepine
The serum concentration of Flunarizine can be decreased when it is combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Flunarizine.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Flunarizine.
Carvedilol
The risk or severity of hypotension can be increased when Carvedilol is combined with Flunarizine.
Casein Allergenic Extract
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Casein.
Caspofungin
The therapeutic efficacy of Caspofungin can be increased when used in combination with Flunarizine.
Celecoxib
The metabolism of Flunarizine can be decreased when combined with Celecoxib.
Ceritinib
The serum concentration of Flunarizine can be increased when it is combined with Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Flunarizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Flunarizine is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Flunarizine.
Chlormethiazole
The risk or severity of adverse effects can be increased when Flunarizine is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Flunarizine is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Chloroprocaine.
Chloroquine
The metabolism of Flunarizine can be decreased when combined with Chloroquine.
Chloroxine
The therapeutic efficacy of Chloroxine can be increased when used in combination with Flunarizine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Flunarizine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Flunarizine.
Chlorpromazine
The metabolism of Flunarizine can be decreased when combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Flunarizine is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Flunarizine.
Cholecalciferol
The metabolism of Flunarizine can be decreased when combined with Cholecalciferol.
Ciclopirox
The therapeutic efficacy of Ciclopirox can be increased when used in combination with Flunarizine.
Cimetidine
The serum concentration of Flunarizine can be increased when it is combined with Cimetidine.
Cinacalcet
The metabolism of Flunarizine can be decreased when combined with Cinacalcet.
Citalopram
The metabolism of Flunarizine can be decreased when combined with Citalopram.
Clemastine
The metabolism of Flunarizine can be decreased when combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Flunarizine.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Flunarizine.
Clobazam
The metabolism of Flunarizine can be decreased when combined with Clobazam.
Clomipramine
The metabolism of Flunarizine can be decreased when combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Clonazepam is combined with Flunarizine.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Flunarizine.
Clopidogrel
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Flunarizine.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Flunarizine.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Flunarizine.
Clotrimazole
The metabolism of Flunarizine can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Flunarizine can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Flunarizine can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Flunarizine can be decreased when combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Flunarizine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Flunarizine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Flunarizine.
Cordycepin
The therapeutic efficacy of Cordycepin can be increased when used in combination with Flunarizine.
Crisaborole
The metabolism of Flunarizine can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Flunarizine can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Flunarizine can be decreased when combined with Curcumin.
Cyclizine
The risk or severity of adverse effects can be increased when Cyclizine is combined with Flunarizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Flunarizine.
Cyclosporine
The metabolism of Flunarizine can be decreased when combined with Cyclosporine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Flunarizine.
Cyproterone Acetate
The serum concentration of Flunarizine can be decreased when it is combined with Cyproterone acetate.
Dabrafenib
The serum concentration of Flunarizine can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Dantrolene is combined with Flunarizine.
Dapiprazole
The risk or severity of adverse effects can be increased when Flunarizine is combined with Dapiprazole.
Darifenacin
The metabolism of Flunarizine can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Flunarizine can be increased when it is combined with Darunavir.
Decanoic Acid
The therapeutic efficacy of Capric acid can be increased when used in combination with Flunarizine.
Deferasirox
The serum concentration of Flunarizine can be increased when it is combined with Deferasirox.
Delavirdine
The metabolism of Flunarizine can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Flunarizine.
Desipramine
The metabolism of Flunarizine can be decreased when combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Flunarizine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Flunarizine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Dexmedetomidine.
Dextroamphetamine
Dextroamphetamine may decrease the sedative activities of Flunarizine.
Dextromoramide
The risk or severity of adverse effects can be increased when Flunarizine is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Flunarizine.
Dibucaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Cinchocaine.
Diethylpropion
Diethylpropion may decrease the sedative activities of Flunarizine.
Difenoxin
The risk or severity of adverse effects can be increased when Difenoxin is combined with Flunarizine.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Flunarizine.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Flunarizine.
Diphenhydramine
The metabolism of Flunarizine can be decreased when combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Flunarizine.
Dothiepin
The metabolism of Flunarizine can be decreased when combined with Dosulepin.
Doxazosin
The risk or severity of hypotension can be increased when Doxazosin is combined with Flunarizine.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Flunarizine.
Doxorubicin
The metabolism of Flunarizine can be decreased when combined with Doxorubicin.
Doxorubicin Hydrochloride
The metabolism of Flunarizine can be decreased when combined with Doxorubicin.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
Dronedarone
The metabolism of Flunarizine can be decreased when combined with Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
Duloxetine
The metabolism of Flunarizine can be decreased when combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Dyclonine.
Econazole
The therapeutic efficacy of Econazole can be increased when used in combination with Flunarizine.
Econazole Nitrate
The therapeutic efficacy of Econazole can be increased when used in combination with Flunarizine.
Efavirenz
The serum concentration of Flunarizine can be decreased when it is combined with Efavirenz.
Efinaconazole
The therapeutic efficacy of Efinaconazole can be increased when used in combination with Flunarizine.
Eliglustat
The metabolism of Flunarizine can be decreased when combined with Eliglustat.
Enflurane
The risk or severity of adverse effects can be increased when Flunarizine is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Flunarizine.
Epinephrine
The risk or severity of hypotension can be increased when Epinephrine is combined with Flunarizine.
Escitalopram
The risk or severity of adverse effects can be increased when Flunarizine is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Flunarizine.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Flunarizine.
Ethanol
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Flunarizine is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Flunarizine.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Flunarizine.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Flunarizine is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Flunarizine is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Flunarizine is combined with Etomidate.
Etravirine
The metabolism of Flunarizine can be decreased when combined with Etravirine.
Ezogabine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Flunarizine.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Flunarizine.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Flunarizine.
Flibanserin
The risk or severity of adverse effects can be increased when Flunarizine is combined with Flibanserin.
Floxuridine
The metabolism of Flunarizine can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Flunarizine can be decreased when combined with Fluconazole.
Flucytosine
The therapeutic efficacy of Flucytosine can be increased when used in combination with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Flunarizine is combined with Flunitrazepam.
Fluorouracil
The metabolism of Flunarizine can be decreased when combined with Fluorouracil.
Fluoxetine
The metabolism of Flunarizine can be decreased when combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Flunarizine.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Flunarizine.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Flunarizine.
Fluspirilene
The risk or severity of adverse effects can be increased when Flunarizine is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Flunarizine.
Fluvastatin
The metabolism of Flunarizine can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Flunarizine can be decreased when combined with Fluvoxamine.
Fosphenytoin
The therapeutic efficacy of Flunarizine can be increased when used in combination with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Flunarizine is combined with Fospropofol.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Flunarizine.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Flunarizine is combined with Gabapentin Enacarbil.
Gemfibrozil
The metabolism of Flunarizine can be decreased when combined with Gemfibrozil.
Glutethimide
The risk or severity of adverse effects can be increased when Flunarizine is combined with Glutethimide.
Glyphosate
The therapeutic efficacy of Glyphosate can be increased when used in combination with Flunarizine.
Griseofulvin
The therapeutic efficacy of Griseofulvin can be increased when used in combination with Flunarizine.
Griseofulvin microsize
The therapeutic efficacy of Griseofulvin can be increased when used in combination with Flunarizine.
Guanfacine
The risk or severity of adverse effects can be increased when Guanfacine is combined with Flunarizine.
Halazepam
The risk or severity of adverse effects can be increased when Flunarizine is combined with Halazepam.
Haloperidol
The metabolism of Flunarizine can be decreased when combined with Haloperidol.
Haloprogin
The therapeutic efficacy of Haloprogin can be increased when used in combination with Flunarizine.
Halothane
The risk or severity of adverse effects can be increased when Flunarizine is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Flunarizine is combined with Heroin.
Hexetidine
The therapeutic efficacy of Hexetidine can be increased when used in combination with Flunarizine.
Hexobarbital
The metabolism of Flunarizine can be increased when combined with Hexobarbital.
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Flunarizine.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Flunarizine.
Hydrocodone
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Flunarizine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
Iloperidone
The risk or severity of adverse effects can be increased when Flunarizine is combined with Iloperidone.
Imipramine
The metabolism of Flunarizine can be decreased when combined with Imipramine.
Indinavir
The metabolism of Flunarizine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Flunarizine can be decreased when combined with Indinavir.
Indoramin
The risk or severity of hypotension can be increased when Indoramin is combined with Flunarizine.
Irbesartan
The metabolism of Flunarizine can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Flunarizine can be decreased when it is combined with Isavuconazole.
Isoconazole
The therapeutic efficacy of Isoconazole can be increased when used in combination with Flunarizine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Flunarizine.
Isoniazid
The metabolism of Flunarizine can be decreased when combined with Isoniazid.
Itraconazole
The therapeutic efficacy of Itraconazole can be increased when used in combination with Flunarizine.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Flunarizine.
Ketazolam
The risk or severity of adverse effects can be increased when Flunarizine is combined with Ketazolam.
Ketoconazole
The metabolism of Flunarizine can be decreased when combined with Ketoconazole.
Labetalol
The risk or severity of hypotension can be increased when Labetalol is combined with Flunarizine.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Flunarizine.
Leflunomide
The metabolism of Flunarizine can be decreased when combined with Leflunomide.
Levetiracetam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Flunarizine.
Levobupivacaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Levodopa is combined with Flunarizine.
Levomethadyl
The risk or severity of adverse effects can be increased when Flunarizine is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Flunarizine is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Flunarizine.
Lidocaine
The metabolism of Flunarizine can be decreased when combined with Lidocaine.
Lisdexamfetamine
Lisdexamfetamine may decrease the sedative activities of Flunarizine.
Lisdexamfetamine Dimesylate
Lisdexamfetamine may decrease the sedative activities of Flunarizine.
Lithium
The risk or severity of adverse effects can be increased when Flunarizine is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Flunarizine is combined with Lithium.
Lofexidine
The therapeutic efficacy of Flunarizine can be increased when used in combination with Lofexidine.
Lopinavir
The metabolism of Flunarizine can be decreased when combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Flunarizine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Flunarizine.
Lorcaserin
The metabolism of Flunarizine can be decreased when combined with Lorcaserin.
Lormetazepam
The risk or severity of adverse effects can be increased when Flunarizine is combined with Lormetazepam.
Losartan
The metabolism of Flunarizine can be decreased when combined with Losartan.
Lovastatin
The metabolism of Flunarizine can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Flunarizine.
Lumacaftor
The serum concentration of Flunarizine can be decreased when it is combined with Lumacaftor.
Lumefantrine
The metabolism of Flunarizine can be decreased when combined with Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Flunarizine.
Magnesium Hydroxide
The risk or severity of hypotension and neuromuscular blockade can be increased when Flunarizine is combined with Magnesium hydroxide.
Magnesium Oxide
The risk or severity of hypotension and neuromuscular blockade can be increased when Flunarizine is combined with Magnesium oxide.
Magnesium Salicylate
The risk or severity of hypotension and neuromuscular blockade can be increased when Flunarizine is combined with Magnesium salicylate.
Magnesium Sulfate
The therapeutic efficacy of Flunarizine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Flunarizine can be increased when used in combination with Magnesium sulfate.
Manidipine
The metabolism of Flunarizine can be decreased when combined with Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Flunarizine.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Flunarizine.
Mefloquine
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Mefloquine.
Melatonin
The risk or severity of adverse effects can be increased when Flunarizine is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Flunarizine.
Mephentermine
Mephentermine may decrease the sedative activities of Flunarizine.
Mephobarbital
The metabolism of Flunarizine can be increased when combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Flunarizine.
Mesoridazine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Flunarizine.
Methadone
The metabolism of Flunarizine can be decreased when combined with Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Flunarizine is combined with Methadyl Acetate.
Methamphetamine
Methamphetamine may decrease the sedative activities of Flunarizine.
Methapyrilene
The risk or severity of adverse effects can be increased when Flunarizine is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Flunarizine is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Flunarizine.
Methohexital
The metabolism of Flunarizine can be increased when combined with Methohexital.
Methotrimeprazine
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Flunarizine is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Flunarizine is combined with Methsuximide.
Metoprolol
The metabolism of Flunarizine can be decreased when combined with Metoprolol.
Metylperon
The risk or severity of adverse effects can be increased when Flunarizine is combined with Melperone.
Metyrosine
Flunarizine may increase the sedative activities of Metyrosine.
Mexiletine
The metabolism of Flunarizine can be decreased when combined with Mexiletine.
Mianserin
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Mianserin.
Micafungin
The therapeutic efficacy of Micafungin can be increased when used in combination with Flunarizine.
Miconazole
The therapeutic efficacy of Miconazole can be increased when used in combination with Flunarizine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Flunarizine.
Midostaurin
The metabolism of Flunarizine can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Flunarizine can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Flunarizine is combined with Milnacipran.
Miltefosine
The therapeutic efficacy of Miltefosine can be increased when used in combination with Flunarizine.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
Mirabegron
The metabolism of Flunarizine can be decreased when combined with Mirabegron.
Mirtazapine
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Molindone
The risk or severity of adverse effects can be increased when Flunarizine is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Flunarizine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
Nafcillin
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Nafcillin.
Naftifine
The therapeutic efficacy of Naftifine can be increased when used in combination with Flunarizine.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Flunarizine.
Natamycin
The therapeutic efficacy of Natamycin can be increased when used in combination with Flunarizine.
Nefazodone
The risk or severity of adverse effects can be increased when Flunarizine is combined with Nefazodone.
Nevirapine
The metabolism of Flunarizine can be increased when combined with Nevirapine.
Nicardipine
The metabolism of Flunarizine can be decreased when combined with Nicardipine.
Nicergoline
The risk or severity of hypotension can be increased when Nicergoline is combined with Flunarizine.
Nicotine
The metabolism of Flunarizine can be decreased when combined with Nicotine.
Nicotine Polacrilex
The metabolism of Flunarizine can be decreased when combined with Nicotine.
Nilotinib
The metabolism of Flunarizine can be decreased when combined with Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Flunarizine.
Nitroprusside
Flunarizine may increase the hypotensive activities of Nitroprusside.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Flunarizine.
Nitroxoline
The therapeutic efficacy of Nitroxoline can be increased when used in combination with Flunarizine.
Nordazepam
The risk or severity of adverse effects can be increased when Flunarizine is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Flunarizine is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Flunarizine is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Flunarizine.
Nystatin
The therapeutic efficacy of Nystatin can be increased when used in combination with Flunarizine.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Flunarizine.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Flunarizine.
Omeprazole
The metabolism of Flunarizine can be decreased when combined with Omeprazole.
Ondansetron
The risk or severity of adverse effects can be increased when Flunarizine is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Flunarizine is combined with Opium.
Orlistat
The serum concentration of Flunarizine can be decreased when it is combined with Orlistat.
Orphenadrine
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Flunarizine can be decreased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Flunarizine.
Oxiconazole
The therapeutic efficacy of Oxiconazole can be increased when used in combination with Flunarizine.
Oxprenolol
The risk or severity of adverse effects can be increased when Flunarizine is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Flunarizine.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Flunarizine.
p-Hydroxyamphetamine
Hydroxyamphetamine may decrease the sedative activities of Flunarizine.
Pafuramidine
The therapeutic efficacy of Pafuramidine can be increased when used in combination with Flunarizine.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Flunarizine.
Panobinostat
The serum concentration of Flunarizine can be increased when it is combined with Panobinostat.
Paraldehyde
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Flunarizine.
Paroxetine
The metabolism of Flunarizine can be decreased when combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Flunarizine can be decreased when it is combined with Peginterferon alfa-2b.
Pentamidine
The therapeutic efficacy of Pentamidine can be increased when used in combination with Flunarizine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Flunarizine.
Pentobarbital
The metabolism of Flunarizine can be increased when combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
Perazine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Perazine.
Periciazine
The risk or severity of hypotension can be increased when Propericiazine is combined with Flunarizine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Flunarizine.
Phenobarbital
The metabolism of Flunarizine can be increased when combined with Phenobarbital.
Phenoxybenzamine
The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Flunarizine.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Flunarizine is combined with Phenoxyethanol.
Phentermine
Phentermine may decrease the sedative activities of Flunarizine.
PHENTERMINE RESIN
Phentermine may decrease the sedative activities of Flunarizine.
Phentolamine
The risk or severity of hypotension can be increased when Phentolamine is combined with Flunarizine.
Phentolamine Mesylate
The risk or severity of hypotension can be increased when Phentolamine is combined with Flunarizine.
Phenytoin
The therapeutic efficacy of Flunarizine can be increased when used in combination with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Flunarizine.
Pipamperone
The risk or severity of adverse effects can be increased when Flunarizine is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Pipotiazine is combined with Flunarizine.
Pirinitramide
The risk or severity of adverse effects can be increased when Flunarizine is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Flunarizine is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Flunarizine is combined with Pomalidomide.
Posaconazole
The therapeutic efficacy of Posaconazole can be increased when used in combination with Flunarizine.
Pramipexole
Flunarizine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Flunarizine is combined with Prazepam.
Prazosin
The risk or severity of hypotension can be increased when Prazosin is combined with Flunarizine.
Pregabalin
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Prilocaine.
Primidone
The metabolism of Flunarizine can be increased when combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Flunarizine.
Promazine
The metabolism of Flunarizine can be decreased when combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Flunarizine.
Proparacaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Proparacaine.
Propiomazine
The risk or severity of hypotension can be increased when Propiomazine is combined with Flunarizine.
Propiverine
The risk or severity of hypotension can be increased when Propiverine is combined with Flunarizine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Flunarizine.
Propoxyphene
The risk or severity of adverse effects can be increased when Flunarizine is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Flunarizine.
Pseudoephedrine
Pseudoephedrine may decrease the sedative activities of Flunarizine.
Pyrimethamine
The metabolism of Flunarizine can be decreased when combined with Pyrimethamine.
Quazepam
The serum concentration of Flunarizine can be increased when it is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Flunarizine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Flunarizine.
Quinidine
The metabolism of Flunarizine can be decreased when combined with Quinidine.
Quinine
The metabolism of Flunarizine can be decreased when combined with Quinine.
Racepinephrine
The risk or severity of hypotension can be increased when Racepinephrine is combined with Flunarizine.
Ramelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Flunarizine.
Ranolazine
The metabolism of Flunarizine can be decreased when combined with Ranolazine.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Flunarizine.
Remoxipride
The risk or severity of adverse effects can be increased when Flunarizine is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Flunarizine.
Rifabutin
The risk or severity of hypotension can be increased when Rifabutin is combined with Flunarizine.
Rifampin
The metabolism of Flunarizine can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Flunarizine can be increased when combined with Rifapentine.
Rifaximin
The risk or severity of hypotension can be increased when Rifaximin is combined with Flunarizine.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Flunarizine.
Ritonavir
The metabolism of Flunarizine can be decreased when combined with Ritonavir.
Rolapitant
The metabolism of Flunarizine can be decreased when combined with Rolapitant.
Ropinirole
Flunarizine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Ropivacaine.
Rotigotine
Flunarizine may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Flunarizine can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Flunarizine.
Salicylic Acid
The therapeutic efficacy of Salicylic acid can be increased when used in combination with Flunarizine.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Flunarizine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Flunarizine.
Secobarbital
The metabolism of Flunarizine can be increased when combined with Secobarbital.
Sertaconazole
The therapeutic efficacy of Sertaconazole can be increased when used in combination with Flunarizine.
Sertindole
The risk or severity of adverse effects can be increased when Flunarizine is combined with Sertindole.
Sertraline
The metabolism of Flunarizine can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Flunarizine.
Sildenafil
The metabolism of Flunarizine can be decreased when combined with Sildenafil.
Silodosin
The risk or severity of hypotension can be increased when Silodosin is combined with Flunarizine.
Simeprevir
The metabolism of Flunarizine can be decreased when combined with Simeprevir.
Sirolimus
The therapeutic efficacy of Sirolimus can be increased when used in combination with Flunarizine.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
Sorafenib
The metabolism of Flunarizine can be decreased when combined with Sorafenib.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Flunarizine.
Sulconazole
The therapeutic efficacy of Sulconazole can be increased when used in combination with Flunarizine.
Sulfadiazine
The metabolism of Flunarizine can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Flunarizine can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Flunarizine can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Flunarizine is combined with Sulpiride.
Suvorexant
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tamsulosin
The risk or severity of hypotension can be increased when Tamsulosin is combined with Flunarizine.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
Tasimelteon
The risk or severity of adverse effects can be increased when Flunarizine is combined with Tasimelteon.
Tavaborole
The therapeutic efficacy of Tavaborole can be increased when used in combination with Flunarizine.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Flunarizine.
Tenofovir Disoproxil
The metabolism of Flunarizine can be decreased when combined with Tenofovir disoproxil.
Terazosin
The risk or severity of hypotension can be increased when Terazosin is combined with Flunarizine.
Terbinafine
The metabolism of Flunarizine can be decreased when combined with Terbinafine.
Terconazole
The therapeutic efficacy of Terconazole can be increased when used in combination with Flunarizine.
Teriflunomide
The serum concentration of Flunarizine can be decreased when it is combined with Teriflunomide.
Tetrabenazine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Flunarizine is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.
Thalidomide
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theophylline
The metabolism of Flunarizine can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Flunarizine can be decreased when combined with Theophylline.
Thiamylal
The metabolism of Flunarizine can be increased when combined with Thiamylal.
Thiopental
The metabolism of Flunarizine can be increased when combined with Thiopental.
Thiopental Sodium
The metabolism of Flunarizine can be increased when combined with Thiopental.
Thioproperazine
The risk or severity of hypotension can be increased when Thioproperazine is combined with Flunarizine.
Thioridazine
The metabolism of Flunarizine can be decreased when combined with Thioridazine.
Thiotepa
The metabolism of Flunarizine can be decreased when combined with Thiotepa.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Flunarizine.
Thymol
The therapeutic efficacy of Thymol can be increased when used in combination with Flunarizine.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Flunarizine.
Tiapride
The risk or severity of adverse effects can be increased when Flunarizine is combined with Tiapride.
Ticagrelor
The metabolism of Flunarizine can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Flunarizine can be decreased when combined with Ticlopidine.
Tioconazole
The therapeutic efficacy of Tioconazole can be increased when used in combination with Flunarizine.
Tipranavir
The metabolism of Flunarizine can be decreased when combined with Tipranavir.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Flunarizine.
Tolazoline
The risk or severity of hypotension can be increased when Tolazoline is combined with Flunarizine.
Tolbutamide
The metabolism of Flunarizine can be decreased when combined with Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Flunarizine.
Tolnaftate
The therapeutic efficacy of Tolnaftate can be increased when used in combination with Flunarizine.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Flunarizine.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Flunarizine.
Tranylcypromine
The metabolism of Flunarizine can be decreased when combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Flunarizine is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Flunarizine.
Triazulenone
The risk or severity of adverse effects can be increased when Flunarizine is combined with Loprazolam.
Tricalcium Phosphate
The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium Phosphate.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Flunarizine.
Triflupromazine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Triflupromazine.
Trimethoprim
The metabolism of Flunarizine can be decreased when combined with Trimethoprim.
Trimetrexate
The therapeutic efficacy of Trimetrexate can be increased when used in combination with Flunarizine.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Flunarizine.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Flunarizine.
Urapidil
The risk or severity of hypotension can be increased when Urapidil is combined with Flunarizine.
Urethane
The risk or severity of adverse effects can be increased when Flunarizine is combined with Ethyl carbamate.
Valproate
The metabolism of Flunarizine can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Flunarizine can be decreased when combined with Valproic Acid.
Valsartan
The metabolism of Flunarizine can be decreased when combined with Valsartan.
Vemurafenib
The serum concentration of Flunarizine can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Flunarizine can be decreased when combined with Venlafaxine.
Verapamil
The risk or severity of hypotension can be increased when Verapamil is combined with Flunarizine.
Vigabatrin
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Flunarizine.
Voriconazole
The metabolism of Flunarizine can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Xylazine.
Zafirlukast
The metabolism of Flunarizine can be decreased when combined with Zafirlukast.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Flunarizine.
Ziconotide
The risk or severity of adverse effects can be increased when Flunarizine is combined with Ziconotide.
Ziprasidone
The metabolism of Flunarizine can be decreased when combined with Ziprasidone.
Zolpidem
Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Flunarizine.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Flunarizine.
Zotepine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Flunarizine.
